retatrutide glp-1 gip glucagon receptor agonist GLP1-GIP receptor co-agonists: a promising

While GLP-1 medications are highly effective for the vast majority of people, the degree of appetite suppression is not universal

Many patients can successfully manage hair loss while continuing their medication by optimizing nutrition, slowing the rate of weight loss through dose adjustment, and adding hair-supportive treatments

For tirzepatide, it explicitly states that the medication is not a reason to discontinue breastfeeding

The injection sites commonly used include the abdomen, thighs, or upper arms

The drug delivered significant weight loss and improvements in a key measure of blood sugar levels in adults with obesity and either Type 2 diabetes or established cardiovascular disease

Heres what to consider when it comes to sustaining weight loss on a GLP-1